05:00 PM EDT, 08/16/2024 (MT Newswires) -- Rocket Pharmaceuticals ( RCKT ) on Friday filed a registration statement with the US Securities and Exchange Commission for the potential sale of securities from time to time in one or more offerings.

The statement covers common and preferred shares, debt securities, warrants, and units, the filing showed.

The company plans to use the net proceeds for general corporate purposes.